Results 271 to 280 of about 128,004 (314)

Coronary Microvascular Dysfunction in Ischaemic Heart Disease: Lessons From Large Animal Models. [PDF]

Basic Clin Pharmacol Toxicol
Sorop O, van de Wouw J, Merkus D, Duncker DJ.   +3 more
europepmc   +1 more source

Preliminary Study of a Ninj1-Loaded Bimodal Ultrasound/NIR Fluorescence Targeted Molecular Probe for Diagnosing Early-Stage Inflammation in Coronary Microvascular Dysfunction. [PDF]

Adv Healthc Mater
Xu X, Guan L, Tayier B, Yuan C, Chen S, Shi Q, Mu Y.   +6 more
europepmc   +1 more source

Persistent Angina With Nonobstructive Coronary Artery Disease: Unmasking Coronary Microvascular Dysfunction Post-Oncotherapy. [PDF]

JACC Case Rep
Macanovic P, Cheng K, Ramasamy A, Baksi J, de Silva R.   +4 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

ISEV2026 Abstract Book

Journal of Extracellular Vesicles, Volume 15, Issue S1, June 2026.
wiley   +1 more source

Coronary Microvascular Dysfunction: A Guide for Clinicians.

The American Journal of Medicine
Dysfunction of the coronary microvasculature has become increasingly recognized as an important mechanism of myocardial ischemia in patients without obstructive coronary artery disease.
Hannah Smati, F. Sellke, J. Bourque, Y. Qadeer, G. Niccoli, R. Montone, C. Krittanawong   +6 more
semanticscholar   +6 more sources

Pharmacological approaches to coronary microvascular dysfunction

Pharmacology & Therapeutics, 2014
In recent decades coronary microvascular dysfunction has been increasingly identified as a relevant contributor to several cardiovascular conditions. Indeed, coronary microvascular abnormalities have been recognized in patients suffering acute myocardial infarction, chronic stable angina and cardiomyopathies, and also in patients with hypertension ...
Giacinta Guarini, Alda Huqi, Doralisa Morrone   +2 more
exaly   +4 more sources

Vascular Remodeling in Coronary Microvascular Dysfunction.

JACC: Cardiovascular Imaging
BACKGROUND Approximately half of the patients with angina and nonobstructive coronary artery disease (ANOCA) have evidence of coronary microvascular dysfunction (CMD).
C. Collet, K. Sakai, T. Mizukami, H. Ohashi, F. Bouisset, S. Caglioni, L. van Hoe, E. Gallinoro, D. Bertolone, S. Pardaens, S. Brouwers, T. Storozhenko, R. Seki, D. Munhoz, Atomu Tajima, D. Buytaert, M. Vanderheyden, E. Wyffels, J. Bartunek, J. Sonck, B. De Bruyne   +20 more
semanticscholar   +5 more sources